Document Detail

The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
MedLine Citation:
PMID:  17264089     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The overall status in rheumatoid arthritis (OSRA) instrument is a simple summary of health status, including disease activity (OSRA-A) and damage (OSRA-D) scores. Despite evidence of the validity of the OSRA, uptake has been low. This study aimed to assess the responsiveness and re-examine the validity of the OSRA using the measures from the British Rheumatoid Outcome Study Group (BROSG) randomized controlled trial of aggressive vs symptomatic treatment of rheumatoid arthritis (RA) patients. METHODS: 466 patients were recruited. Outcome measures included the OSRA, the OMERACT core set and the DAS28, and were collected at baseline and annually for the 3 yrs of the trial. X-rays of the hands and feet were taken at baseline and 3 yrs. Patients were assigned a Townsend score (a measure of social deprivation) according to area of residence. Construct validity was assessed by correlating the OSRA with a range of outcome measures, and testing for the known inequality in RA outcome between patients classified by social deprivation. Responsiveness to change was assessed against self-reported change over the first year of the trial. RESULTS: The OSRA-A and OSRA-D measures demonstrated construct validity, performing as hypothesized. The OSRA-A was the most responsive measure in the BROSG trial in detecting patient reported improvement and deterioration. The OSRA-D demonstrated similar responsiveness to alternative measures. CONCLUSIONS: Our results demonstrate the validity and responsiveness of the OSRA, and its potential for inclusion in clinical trials. More important, as the OSRA is quick and easily calculated, uses routinely collected information, and provides useful quantitative information about a patient's status and progress it is suitable for use in the routine clinic.
M J Harrison; A Hassell; P T Dawes; D L Scott; S M Knight; M J Davis; D Mulherin; D P M Symmons
Related Documents :
16534659 - Psychological symptoms following smoking cessation in pregnant smokers.
8819019 - Development of a scale to measure discomfort during pregnancy.
10843029 - Trends in smoking during pregnancy, wisconsin 1990 to 1996.
24420719 - Novel insights into early embryonic demise via 3d surface rendered imaging in 107 cases.
8996259 - Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyri...
1706089 - Gastrin-releasing peptide gene products in midtrimester human fetal lung with and witho...
7254949 - Fetal-like erythropoiesis during recovery from transient erythroblastopenia of childhoo...
19526429 - Maternal and fetal outcome of pregnancy complicated by hellp syndrome.
7120209 - Sexuality and pregnancy. a prospective study.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Studies     Date:  2007-01-30
Journal Detail:
Title:  Rheumatology (Oxford, England)     Volume:  46     ISSN:  1462-0324     ISO Abbreviation:  Rheumatology (Oxford)     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-04-23     Completed Date:  2007-07-03     Revised Date:  2007-09-06    
Medline Journal Info:
Nlm Unique ID:  100883501     Medline TA:  Rheumatology (Oxford)     Country:  England    
Other Details:
Languages:  eng     Pagination:  849-55     Citation Subset:  AIM; IM    
arc Epidemiology Unit, The University of Manchester, Department of Rheumatology, University Hospital of North Staffordshire NHS Trust, Oxford Road Manchester, M13 9PT, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / diagnosis*,  drug therapy,  rehabilitation
Disease Progression
Epidemiologic Methods
Health Status Indicators*
Middle Aged
Quality of Life
Severity of Illness Index
Socioeconomic Factors
Treatment Outcome
Reg. No./Substance:
0/Antirheumatic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A new computerized method for the assessment of skin lesions in localized scleroderma.
Next Document:  Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis.